Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792688 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation
A Phase 2 study of Wounds, sponsored by TR Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00792688 is a Phase 2 study of Wounds that has completed, run by TR Therapeutics. The registered enrollment target is 26 participants, below the 99-participant average among 6 other Wounds trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00792688, a Phase 2 study of Wounds, has completed, sponsored by TR Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are to evaluate safety and efficacy of topically applied Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower eyelids. The study will observe the effects of the topical agent over the course of 1 month following the initial treatment.
Conditions Studied
Interventions
- DRUG GLYC-101 Gel (0.1%)
- DRUG GLYC-101 Gel (1.0%)
- DRUG GLYC-101 Placebo
Study Locations (1)
California
- CLINICAL TESTING CENTER of BEVERLY HILLS - Beverly Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792688
The ClinicalTrials.gov registry entry for NCT00792688 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 6 other Wounds trials with a reported enrollment target (74% lower). The listed sponsor is TR Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wounds appearing as the primary indexed condition, and to 3 interventions - of which GLYC-101 Gel (0.1%) is the first listed.
NCT00792688 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00792688 about?
NCT00792688 is a clinical study titled "Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation". The primary objectives of this study are to evaluate safety and efficacy of topically applied Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower eyelids. The study will obs...
What is the current status of trial NCT00792688?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2008-10. Estimated completion is 2010-01.
What conditions does trial NCT00792688 study?
This clinical trial studies the following conditions: Wounds.
What interventions are being tested in trial NCT00792688?
The interventions under investigation include: GLYC-101 Gel (0.1%) (DRUG), GLYC-101 Gel (1.0%) (DRUG), GLYC-101 Placebo (DRUG).
Who is sponsoring clinical trial NCT00792688?
This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00792688 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
4-aminopyridine for Skin Wound Healing
RECRUITING · Phase 2
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing
RECRUITING · NA
-
Octylseal Surgical Adhesive in General Surgery
COMPLETED · Phase 4
-
Platelets in Acute Wounds: A Pilot Study (PAWS)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.